Delivery Order SPE2DX22D0010-SPE2D823FCU92
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,155.88 and an ultimate completion date of December 8, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,318.85 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 15, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,481.50 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical products and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order valued at $9,132.72 with a completion date of June 10, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,714.22 for pharmaceutical and medical supply distribution. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 3, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., covers the delivery of a broad range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $2,116.41, is a Firm Fixed Price Delivery Order with a period of performance through December 21, 2022. Amerisourcebergen, a large pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a broad range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $78,044.67, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,591.28 for pharmaceutical and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract has a performance period through May 18, 2021 and is a firm fixed-price contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,777.15, is a Firm Fixed Price Delivery Order with a completion date of February 12, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D823FCU92Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $16,824.71 for the provision of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of January 12, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 1/11/23 |